28
Views
29
CrossRef citations to date
0
Altmetric
Original Article

Effect of Orchidectomy on Serum Concentrations of Testosterone and Dihydrotestosterone in Patients with Prostatic Cancer

&
Pages 11-14 | Received 16 May 1990, Accepted 17 Dec 1990, Published online: 15 Feb 2010

REFERENCES

  • Bartsch W, Horst HJ, Becker H, Nehse G. Sex hormone binding globulin binding capacity, testosterone, 5α-dihydrotestosterone, oestradiol and prolactin in plasma of patients with prostatic carcinoma under various types of hormone treatment. Acta Endocrinol 1977; 85: 650–664.
  • Bartsch W, Steins P, Becker H. Hormone blood levels in patients with prostatic carcinoma and their relation to the type of carcinoma growth differentiation. Eur Urol 1977; 3: 47–52.
  • Ghanadian R, Puah CM, O'Donoghue EPN. Serum testosterone and dihydrotestosterone in carcinoma of the prostate. Br J Cancer 1979; 39: 696–699.
  • Hammond GL, Ruokonen A, Kontturi M, Koskela E, Vihko R. The simultaneous radioimmunoassay of seven steroids in human spermatic and peripheral venous blood. J Clin Endocrinol 1977; 45: 16–24.
  • Harper ME, Pike A, Peeling WB, Griffiths K. Steroids of adrenal origin metabolized by human prostatic tissue both in vivo and in vitro. J Endocrinol 1974; 60: 117–125.
  • Huggins C, Stevens RE, Hodges CV. Studies on prostatic cancer. Arch Surg 1941; 43: 209–223.
  • Lukkarinen O, Hammond GL, Kontturi M, Vihko R. Long-term effects of endocrine treatment on serum steroids in advanced prostatic carcinoma patients. Investigative Urology 1980; 17: 328–331.
  • Mainwaring WIP. The relevance of studies on androgen action to prostatic cancer. Endocrinology 1976; 4: 152–171.
  • Parker CR, Ellegood JO, Mahesh VB. Methods for multiple steroid radioimmunoassay. J Steroid Biochem 1975; 6: 1–8.
  • Parker CR, Ellegood JO, Mahesh VB. Comparative evaluation of antisera for 5α-dihydrotestosterone radioimmunoassay. J Steroid Biochem 1975; 6: 9–13.
  • Petrow V. The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications. Prostate 1986; 9: 343–361.
  • Saroff J, Kirdani RY, Chu TM, Wajsman Z, Murphy GP. Measurements of prolactin and androgens in patients with prostatic diseases. Oncology 1980; 37: 46–52.
  • Sciarra F, Piro C, Toscano V, Petrangeli E, Caiola S, Di Silverio F, Bracci U, Conti C. Plasma testosterone, dihydrotestosterone, and rostenedione, 3α and 3β androstanediols, free testosterone fraction and sex hormone binding globulin capacity in prostatic adenocarcinoma. Exerpta Med Int Congr Ser 1981; 515: 93–102.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.